Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Genetics and Cytogenetics

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cancergencyto.2010.08.009PMID 21156226PMCID PMC3763815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American College of Medical Genetics STANDARDS AND GUIDELINES FOR CLINICAL GENETICS LABORATORIES

  2011cited by this paper
• A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B‐chronic lymphocytic leukaemia

  2010cited by this paper
• Predicting clinical outcome in CLL: how and why.

  2009cited by this paper
• De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience.

  2008cited by this paper
• Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

  2007cited by this paper
• Preclinical validation of fluorescence in situ hybridization assays for clinical practice

  2006influential reference
• Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.

  2005cited by this paper
• Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.

  2005cited by this paper
• Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia

  2005cited by this paper
• Hematopathology in Oncology

  2004cited by this paper
• A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia

  2004cited by this paper
• Molecular cytogenetic studies for hematological malignancies.

  2004cited by this paper
• Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

  2004cited by this paper
• Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B‐cell chronic lymphocytic leukaemia

  2003cited by this paper
• A multicenter investigation with D-FISH BCR/ABL1 probes.

  2000cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.

  1998cited by this paper
• A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes.

  1998cited by this paper
• Toward quality assurance for metaphase FISH: a multi-center experience.

  1996cited by this paper
• Toward quality assurance for metaphase FISH: a multicenter experience.

  1996cited by this paper

• Genomic Aberration Detection by Fluorescence in Situ Hybridization.

  2025cites this paper
• Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations

  2024cites this paper
• Serum B-Cell Maturation Antigen is an Independent Prognostic Marker in Previously Untreated Chronic Lymphocytic Leukemia.

  2022cites this paper
• PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia

  2021cites this paper
• Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia

  2020cites this paper
• IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

  2019cites this paper
• 13 Genetics of Chronic Lymphocytic Leukemia : Practical Aspects and Prognostic Significance

  2017cites this paper
• Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran

  2017cites this paper
• Using Murine Models to Understand Tumor-Lymphoid Interactions: Spotlight on CLL and AITL

  2017cites this paper
• Using Murine Models to Investigate Tumor–Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma

  2017cites this paper
• Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

  2016cites this paper
• Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease

  2016cites this paper
• The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience

  2016cites this paper
• Incidence of chromosomal anomalies detected by interphase FISH in chronic lymphoid leukemia

  2015cites this paper
• Mutations driving CLL and their evolution in progression and relapse

  2015cites this paper
• Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort

  2015cites this paper
• Mutations driving CLL and their evolution in progression and relapse

  2015cites this paper
• Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.

  2014cites this paper
• Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.

  2014cites this paper
• MDM2 promoter SNP309 mutation and HS1 expression in chronic lymphocytic leukemia patients ( exploring their assumed prognostic value)

  2013cites this paper
• Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

  2013cites this paper
• Tumor-induced host immunosuppression: special focus on CLL.

  2013cites this paper
• Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.

  2013cites this paper
• Cytogenetics in myelodysplastic syndromes: old methods, new clues.

  2012influential citation
• Cytogenetic and genomic assessment of selected lymphoproliferative disorders

  2012cites this paper
• Genetics of Chronic Lymphocytic Leukemia: Practical Aspects and Prognostic Significance

  2012cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Identifying High-risk Chronic Lymphocytic Leukemia: a Pathogenesis-oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy

  year unknowncites this paper
• DigitalCommons@UNO DigitalCommons@UNO

  year unknowncites this paper